Takeda Pharmaceutical (TAK) Dividends Paid - Common (QoQ) (2018 - 2026)
Takeda Pharmaceutical (TAK) Dividends Paid - Common (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 504.97% |
| Dec 31, 2025 | -1,523.86% |
| Sep 30, 2025 | 94.06% |
| Jun 30, 2025 | -125.71% |
| Mar 31, 2025 | 508.26% |
| Dec 31, 2024 | -1,451.36% |
| Sep 30, 2024 | 93.05% |
| Jun 30, 2024 | -123.24% |
| Mar 31, 2024 | 508.24% |
| Dec 31, 2023 | -1,390.05% |
| Sep 30, 2023 | 93.42% |
| Jun 30, 2023 | -123.06% |
| Mar 31, 2023 | 553.18% |
| Dec 31, 2022 | -1,032.57% |
| Sep 30, 2022 | 91.91% |
| Jun 30, 2022 | -120.78% |
| Mar 31, 2022 | 514.67% |
| Dec 31, 2021 | -1,234.26% |
| Sep 30, 2021 | 92.81% |
| Jun 30, 2021 | -122.86% |